These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

229 related articles for article (PubMed ID: 21731701)

  • 1. Functional role of dimerization of human peptidylarginine deiminase 4 (PAD4).
    Liu YL; Chiang YH; Liu GY; Hung HC
    PLoS One; 2011; 6(6):e21314. PubMed ID: 21731701
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Functional roles of the non-catalytic calcium-binding sites in the N-terminal domain of human peptidylarginine deiminase 4.
    Liu YL; Tsai IC; Chang CW; Liao YF; Liu GY; Hung HC
    PLoS One; 2013; 8(1):e51660. PubMed ID: 23382808
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Molecular Interplay between the Dimer Interface and the Substrate-Binding Site of Human Peptidylarginine Deiminase 4.
    Lee CY; Lin CC; Liu YL; Liu GY; Liu JH; Hung HC
    Sci Rep; 2017 Feb; 7():42662. PubMed ID: 28209966
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Kinetic characterization of protein arginine deiminase 4: a transcriptional corepressor implicated in the onset and progression of rheumatoid arthritis.
    Kearney PL; Bhatia M; Jones NG; Yuan L; Glascock MC; Catchings KL; Yamada M; Thompson PR
    Biochemistry; 2005 Aug; 44(31):10570-82. PubMed ID: 16060666
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Discovery of peptidylarginine deiminase-4 substrates by protein array: antagonistic citrullination and methylation of human ribosomal protein S2.
    Guo Q; Bedford MT; Fast W
    Mol Biosyst; 2011 Jul; 7(7):2286-95. PubMed ID: 21584310
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Citrullination of inhibitor of growth 4 (ING4) by peptidylarginine deminase 4 (PAD4) disrupts the interaction between ING4 and p53.
    Guo Q; Fast W
    J Biol Chem; 2011 May; 286(19):17069-78. PubMed ID: 21454715
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Recognition of the N-terminal histone H2A and H3 peptides by peptidylarginine deiminase IV.
    Saiki M; Watase M; Matsubayashi H; Hidaka Y
    Protein Pept Lett; 2009; 16(9):1012-6. PubMed ID: 19508226
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Structural basis for histone N-terminal recognition by human peptidylarginine deiminase 4.
    Arita K; Shimizu T; Hashimoto H; Hidaka Y; Yamada M; Sato M
    Proc Natl Acad Sci U S A; 2006 Apr; 103(14):5291-6. PubMed ID: 16567635
    [TBL] [Abstract][Full Text] [Related]  

  • 9. PAD4-dependent citrullination of nuclear translocation of GSK3β promotes colorectal cancer progression via the degradation of nuclear CDKN1A.
    Luo X; Chang S; Xiao S; Peng Y; Gao Y; Hu F; Liang J; Xu Y; Du K; Chen Y; Qin J; Meltzer SJ; Deng S; Feng X; Fan X; Hou G; Jin Z; Zhang X
    Neoplasia; 2022 Nov; 33():100835. PubMed ID: 36113195
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Probing the Roles of Calcium-Binding Sites during the Folding of Human Peptidylarginine Deiminase 4.
    Liu YL; Lee CY; Huang YN; Chen HY; Liu GY; Hung HC
    Sci Rep; 2017 May; 7(1):2429. PubMed ID: 28546558
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Structures of human peptidylarginine deiminase type III provide insights into substrate recognition and inhibitor design.
    Funabashi K; Sawata M; Nagai A; Akimoto M; Mashimo R; Takahara H; Kizawa K; Thompson PR; Ite K; Kitanishi K; Unno M
    Arch Biochem Biophys; 2021 Sep; 708():108911. PubMed ID: 33971157
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Anti-peptidylarginine deiminase-4 antibodies at mucosal sites can activate peptidylarginine deiminase-4 enzyme activity in rheumatoid arthritis.
    Demoruelle MK; Wang H; Davis RL; Visser A; Hoang J; Norris JM; Holers VM; Deane KD; Darrah E
    Arthritis Res Ther; 2021 Jun; 23(1):163. PubMed ID: 34092252
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Crystal structure of human peptidylarginine deiminase type VI (PAD6) provides insights into its inactivity.
    Ranaivoson FM; Bande R; Cardaun I; De Riso A; Gärtner A; Loke P; Reinisch C; Vogirala P; Beaumont E
    IUCrJ; 2024 May; 11(Pt 3):395-404. PubMed ID: 38656308
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Revamped role for approved drug: integrative computational and biophysical analysis of saquinavir's peptidyl arginine deiminase 4 inhibition for rheumatoid arthritis.
    Thirugnanasambandham I; Jupudi S; Roychowdhury P; Karri VVSR; Madhunapantula SRV; Singh SK; Subramaniyan V; Kuppusamy G
    Biochem J; 2024 Oct; 481(20):1379-1393. PubMed ID: 39312210
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Coordination of PAD4 and HDAC2 in the regulation of p53-target gene expression.
    Li P; Wang D; Yao H; Doret P; Hao G; Shen Q; Qiu H; Zhang X; Wang Y; Chen G; Wang Y
    Oncogene; 2010 May; 29(21):3153-62. PubMed ID: 20190809
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Structural and biochemical analyses of the human PAD4 variant encoded by a functional haplotype gene.
    Horikoshi N; Tachiwana H; Saito K; Osakabe A; Sato M; Yamada M; Akashi S; Nishimura Y; Kagawa W; Kurumizaka H
    Acta Crystallogr D Biol Crystallogr; 2011 Feb; 67(Pt 2):112-8. PubMed ID: 21245532
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Regulation of p53 target gene expression by peptidylarginine deiminase 4.
    Li P; Yao H; Zhang Z; Li M; Luo Y; Thompson PR; Gilmour DS; Wang Y
    Mol Cell Biol; 2008 Aug; 28(15):4745-58. PubMed ID: 18505818
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Dual roles of Lys(57) at the dimer interface of human mitochondrial NAD(P)+-dependent malic enzyme.
    Hsieh JY; Liu JH; Fang YW; Hung HC
    Biochem J; 2009 May; 420(2):201-9. PubMed ID: 19236308
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Dysregulation of PAD4-mediated citrullination of nuclear GSK3β activates TGF-β signaling and induces epithelial-to-mesenchymal transition in breast cancer cells.
    Stadler SC; Vincent CT; Fedorov VD; Patsialou A; Cherrington BD; Wakshlag JJ; Mohanan S; Zee BM; Zhang X; Garcia BA; Condeelis JS; Brown AM; Coonrod SA; Allis CD
    Proc Natl Acad Sci U S A; 2013 Jul; 110(29):11851-6. PubMed ID: 23818587
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Peptidyl arginine deiminase-4 activation exacerbates kidney ischemia-reperfusion injury.
    Ham A; Rabadi M; Kim M; Brown KM; Ma Z; D'Agati V; Lee HT
    Am J Physiol Renal Physiol; 2014 Nov; 307(9):F1052-62. PubMed ID: 25164081
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.